Study compares effectiveness of 2 vs. 3 doses of HPV vaccine for girls and young women
With the number of doses and cost of human papillomavirus (HPV) vaccines a barrier to global implementation, researchers have found that girls who received two doses of HPV vaccine had immune responses to HPV-16 and HPV-18 ...
Cancer
Apr 30, 2013 |
not rated yet |
0
Study offers clues to making vaccine for infant respiratory illness
An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common—and sometimes very serious—childhood disease. ...
Diseases, Conditions, Syndromes
Apr 25, 2013 |
not rated yet |
0
|
Patients with chronic fatigue use additional areas of brain when using memory
(Medical Xpress)—Scientists studying the brain scans of chronic fatigue patients have found they use additional brain regions to do simple tasks requiring attention. This may explain the problems many sufferers ...
Diseases, Conditions, Syndromes
Apr 23, 2013 |
5 / 5 (1) |
0
Team finds antibody that transforms bone marrow stem cells directly into brain cells
In a serendipitous discovery, scientists at The Scripps Research Institute (TSRI) have found a way to turn bone marrow stem cells directly into brain cells.
Medical research
Apr 22, 2013 |
5 / 5 (11) |
2
|
Novel monoclonal antibody inhibits tumor growth in breast cancer and angiosarcoma
A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.
Cancer
Apr 19, 2013 |
5 / 5 (2) |
0
|
Scientists find ethnicity linked to antibodies
(Medical Xpress)—Cracking the DNA code for a complex region of the human genome has helped 14 North American scientists, including five at Simon Fraser University, chart new territory in immunity research.
Genetics
Apr 17, 2013 |
5 / 5 (2) |
0
|
Molecule treats leukemia by preventing cancer cell repair, scientists report
(Medical Xpress)—Researchers at The Jackson Laboratory have identified a molecule that prevents repair of some cancer cells, providing a potential new "genetic chemotherapy" approach to cancer treatment ...
Cancer
Apr 17, 2013 |
4.7 / 5 (3) |
0
|
Peptides for the treatment of severe diseases
A new class of drugs for the treatment of severe diseases such as cancer and autoimmune diseases is developed by the start-up Bicycle Therapeutics. The company is generating bicyclic peptides that can selectively ...
Medical research
Apr 15, 2013 |
5 / 5 (1) |
0
Discovery points to new approach to fight dengue virus
Researchers have discovered that rising temperature induces key changes in the dengue virus when it enters its human host, and the findings represent a new approach for designing vaccines against the aggressive ...
Diseases, Conditions, Syndromes
Apr 11, 2013 |
5 / 5 (1) |
0
|
Engineered antibody demonstrated safety, efficacy in wide range of advanced tumors
(Medical Xpress)—The engineered antibody MPDL3280A, which targets a protein called programmed death-ligand 1 (PD-L1), was safe and effective for several cancers, according to phase I study results presented at the AACR ...
Cancer
Apr 10, 2013 |
4 / 5 (1) |
0
Ranibizumab may prevent retinal detachment side effect
Proliferative vitreoretinopathy (PVR), or the formation of scar tissue in the eye, is a serious, sight-threatening complication in people recovering from surgical repair of retinal detachment. PVR is difficult to predict, ...
Ophthalmology
Apr 09, 2013 |
5 / 5 (1) |
0
Delayed allergy reactions seen with pediatric meat consumption
(HealthDay)—Immunoglobulin E (IgE) antibody specific for galactose-α1,3-galactose (α-Gal), which is associated with delayed anaphylaxis and urticaria that occurs several hours after eating beef, pork, ...
Pediatrics
Apr 09, 2013 |
not rated yet |
0
Research advances therapy to protect against dengue virus
Nearly half of the world's population is at risk of infection by the dengue virus, yet there is no specific treatment for the disease. Now a therapy to protect people from the virus could finally be a step ...
Diseases, Conditions, Syndromes
Apr 08, 2013 |
not rated yet |
0
|
Targeted toxin active in platinum-resistant ovarian cancers
A new antibody-guided drug has shown promising activity in a phase I trial involving ovarian cancer patients with platinum drug-resistant disease, researchers from Dana-Farber Cancer Institute will report today at the annual ...
Cancer
Apr 06, 2013 |
not rated yet |
0
Hepatitis A virus discovered to cloak itself in membranes hijacked from infected cells
Viruses have historically been classified into one of two types – those with an outer lipid-containing envelope and those without an envelope. For the first time, researchers at the University of North ...
Diseases, Conditions, Syndromes
Apr 04, 2013 |
5 / 5 (3) |
1
|
